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Abstract
Background: Placental cytokines play crucial roles in the establishment and maintenance of pregnancy as well as protecting
the foetus from infections. Previous studies have suggested the implication of infections such as P. falciparum and HIV in the
stimulation of placental cytokines. This study assessed the impact of P. falciparum on placental cytokine profiles between
HIV-1 positive and negative women.
Materials and Methods: P. falciparum infection was checked in peripheral and placental blood of HIV-1 negative and
positive women by the thick blood smear test. Cytokines proteins and messenger RNAs were quantified by ELISA and real
time PCR, respectively. Non-parametric tests were used for statistical analyses.
Results: Placental and peripheral P. falciparum infections were not significantly associated with HIV-1 infection (OR: 1.4; 95%
confidence interval (95%CI): 0.5–4.2; p=0.50 and OR: 0.6; 95%CI: 0.3–1.4; p=0.26, respectively). Conversely, placental P.
falciparum parasitemia was significantly higher in the HIV-1 positive group (p=0.04). We observed an increase of TNF-a
mRNA median levels (p=0.02) and a trend towards a decrease of IL-10 mRNA (p=0.07) in placenta from HIV-1 positive
women compared to the HIV negative ones leading to a median TNF-a/IL-10 mRNA ratio significantly higher among HIV-1
positive than among HIV-1 negative placenta (p=0.004; 1.5 and 0.8, respectively). Significant decrease in median secreted
cytokine levels were observed in placenta from HIV-1 positive women as compared to the HIV negative however these
results are somewhat indicative since it appears that differences in cytokine levels (protein or mRNA) between HIV-1 positive
and negative women depend greatly on P.falciparum infection. Within the HIV-1 positive group, TNF-a was the only
cytokine significantly associated with clinical parameters linked with HIV-1 MTCT such as premature rupture of membranes,
CD4 T-cell number, plasma viral load and delay of NVP intake before delivery.
Conclusions: These results show that P. falciparum infection profoundly modifies the placenta cytokine environment and
acts as a confounding factor, masking the impact of HIV-1 in co-infected women. This interplay between the two infections
might have implications in the in utero MTCT of HIV-1 in areas where HIV-1 and P. falciparum co-circulate.
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Introduction
Malaria and HIV/AIDS are two of the most common and
important health problems in sub-Saharan African countries, and
pregnant women are a particularly vulnerable group [1]. In
pregnant women, the placenta provides a favourable environment
for interactions between these two infections [2].
The placental barrier separates the mother’s blood circulation
from that of the fetus. The placental environment consists of
several soluble factors including hormones [3,4], maternal
antibodies [5,6] and cytokines [7]. Cytokines in particular have
regulatory activities on the initiation and maintenance of
pregnancy [8,9].
In the specific case of HIV-1 infected pregnant women, cytokines
interact with HIV-1 in several ways. They could either inhibit
(Interferons and anti-inflammatory cytokines) [10,11] or enhance
(pro-inflammatory cytokines) HIV-1 replication [12,13] or display
both effects, depending on the target cells [14,15]. Several authors
have suggested that cytokines could be major regulators of
transplacental transmission of HIV-1 [12,16–20]. Moreover,
PLoS ONE | www.plosone.org 1 December 2009 | Volume 4 | Issue 12 | e8114granulocyte macrophage colony-stimulating factor (GM-CSF),
interleukin-1 beta (IL-1b) and TNF-a have been shown to stimulate
HIV-1 transcriptional modulation in placental derived trophoblas-
tic cells [13]. Our previous studies showed that TNF-a could
increase HIV-1 transcriptional modulation in infected placenta
tissues [21]. Conversely, the principal characteristic of HIV-1
infection is its profound impairment of the immune system. This
impairment, characterized by a generalized immune activation and
a CD4 T-cell depletion has, as consequence among others, a
dramatic modification of cytokine and chemokine profiles [22,23].
Chronic immune activation is also a hallmark of the immune
system of parasitized individuals in malaria endemic areas.
Pregnant women are progressively less susceptible to malaria
during successive pregnancies [24,25]. This successive resistance
pattern to pregnancy-associated malaria (PAM) has been related to
the successive acquisition of antibodies that inhibit adhesion of P.
falciparum–infected erythrocytes to the placental receptor, chon-
droitin sulphate A (CSA) [26]. This observation is consistent with
evidence that these antibodies are the mediators of protective
immunity to PAM [27–29]. Several studies have documented
increased secretion of cytokines such as TNF-a, IL-1, IL-6 and IL-
10 by P. falciparum infected placentae [25,30–32]. These cytokine
profile modifications during PAM have several drawbacks. For
instance high levels of TNF-a have been shown to be associated
with delivery of low birth weight children born to women with P.
falciparum infected placenta [33]. Thus, malaria infection impairs
normal functions of the immune system with further complications
if it occurs during pregnancy.
Considering the high levels of mother-to-child transmission
(MTCT) of HIV-1 in malaria endemic countries, it could be
suggested that placental malaria is a risk factor associated with in utero
MTCTofHIV-1.Malariacouldachievethisrolethroughalterations
oftheplacentalcytokineenvironmentinHIV-1positivewomen[34].
In this context, the cytokine profiles in HIV-1 infected pregnant
women, as compared to a group of uninfected women could give
additional information on the interplay between HIV-1 and malaria
at the placenta level and in areas where both infections co-circulate.
This study was therefore initiated with the principal aim of
studying the mRNA expression or secretion of placental cytokines
in HIV-1 uninfected women compared to infected women who
accepted to take NVP at the beginning of labour for the
prevention of MTCT of HIV-1, as was practiced in this country
at the time of the study, taking into account P. falciparum infection.
Results
Characteristics of the studied groups
Between the HIV-1 positive and negative pregnant women who
participated in this study, there were no statistically significant
differences in age, term of delivery, proportion of women with
ruptured membranes more than 4 hours, birth weight of children,
and the presence of infections other than HIV-1 (Hepatitis B or C
Viruses, Syphilis, peripheral blood or placental P. falciparum
infections) (Table 1). Nevertheless, a significant difference
(p=0.03) was observed between the two groups in the proportion
of women in first pregnancy. Indeed, the present pregnancy was
the first one for only 19% of HIV-1 positive women, while it
represented 36% for HIV-1 negative women (Table 1). P.
falciparum placental infection was not significantly associated with
HIV-1 infection (odds ratio (OR): 1.4; 95% confidence interval
(95%CI): 0.5–4.2; p=0.50, Table 1). However parasitemia was
significantly higher (p=0.04) in the placenta of HIV-1 positive
women (Table 2). Similarly, a trend of a higher P. falciparum
parasitemia was also observed in the peripheral blood circulation
(p=0.08, Table 2), while peripheral blood P. falciparum infection
was not significantly associated with HIV-1 infection (OR: 0.6;
95%CI: 0.3–1.4: p=0.26, Table 1).
Significantly lower median haemoglobin (p,0.001) and neutro-
phils (p=0.002) levels were observed in HIV-1 positive compared to
HIV-1negative women (SupplementaryFigureS1).HIV-1 specific
characteristicsindicateamedianviralloadof4.0log10(inter-quartile
range (IQR) of 3.1–4.5 log10), a median CD4+ T-cell count at
deliveryof364 cells/mm
3 (IQR=245–504 cells/mm
3). The median
time of NVP intake before delivery was 5 hours (IQR=4–8 hours).
Table 1. General characteristics of the women recruited in the study.
Characteristics HIV-1 Negative women HIV-1 Positive women p*
N=50 n=80
Age at inclusion (years)
median (IQR) 25.2 (21.5–30.0) 26.6 (23.3–31.0) 0.10
2
First Pregnancy n (%)
Yes 18 (36) 15 (19) 0.03
1
Pregnancy duration (weeks) 39.6 (38.9–40.9) 39.4 (38.3–40.6) 0.15
2
Birth weight (kg)
median (IQR) 3.3 (2.9–3.5) 3.2 (2.8–3.5) 0.58
Ruptured membranes .4 hours
n (%) 7 (14) 4 (5) 0.07
2
Other infections at inclusion
HBV n (%) 2/50 (4) 7/78 (9) 0.28
HCV n (%) 2/50 (4) 1/80 (1) 0.31
Syphilis n (%) 1/21 (5) 6/65 (9) 0.51
Peripheral blood P.falciparum, n (%) 14/50 (28) 15/77 (19) 0.26
Placental P.falciparum, n (%) 8/45 (18) 9/38 (24) 0.50
*Median values and Interquartile ranges (IQR) are presented. 1=Significant difference (p,0.05); 2=tendencies (0.15.p.0.05); ND=not determined.
doi:10.1371/journal.pone.0008114.t001
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were tested for HIV-1infection 6 to 8 weeks after birth. Seven (11%)
of the 64 children were HIV infected and presented high viral load,
between 5 and 5.7 log10 during the first 6 to 8 weeks of life. All of the
7 infected children were of the female gender.
Comparison of placental cytokine profiles between HIV-1
positive and negative women
The levels of placental cytokine mRNA expression of SDF-1,
IL-7, IL-10, TNF-a, and IL-8 were compared between HIV-1
positive and negative women. As shown in Figure 1, variable
levels of each cytokine were observed within each group (HIV-1
positive or negative). The levels of IL-8 were high in both groups,
while expression levels of IL-7 were the lowest. The median levels
of RNA expression for any given cytokine, except TNF-a and IL-
10, were similar in HIV-1 negative and positive women. For TNF-
a, there was a significant increase (p=0.02) and a trend of an IL10
decrease (p=0.07) in HIV positive women as compared to HIV
negative women, leading to a significant increase of the ratio TNF-
a/IL10 (p=0.004). The median TNF-a/IL-10 ratio among HIV-
1 positive women (median: 1.5, inter-quartile range: 0.7–4.1) was
significantly higher than among HIV-1 negative women (median:
0.8; inter-quartile range: 0.4–1.8).
After a 24-hour culture of fresh placental fragments, cytokine
secretion levels were measured in the culture supernatants
(Figure 2). The following cytokines were analysed and compared
between HIV-1 positive and negative women: IL-16, IL-7,
RANTES, IL-15, TNF-a, IL-10, IL-8, and LIF. In both groups,
high and variable values were observed for IL-16, RANTES and
IL-8, while low values were observed for IL-7, IL-15 and LIF, low
to undetectable levels were obtained for IL-10 (data not shown). In
0%, 94%, 22%, 4% and 22% of HIV-1 negative placentas and in
56%, 100%, 49%, 1% and 41% of HIV-1 positive placentas,
secretion levels of IL-7, IL-10, TNF-a, IL8 and LIF, respectively,
were not detectable. TNF-a to IL10 ratio could not be calculated
at the protein level because IL-10 protein in the supernatants was
below the detection level (5pg/ml) for all the 80 placentae of HIV-
1 positive women and for 47 out of 50 placentae of HIV-1 negative
women. IL7, TNF-a, LIF, IL16 and RANTES median levels were
decreased in HIV positive women as compared to HIV negative
women (p,0.001, p=0.07, p=0.03, p=0.004 and p=0.04,
respectively).
Table 2. P. falciparum parasitemia among HIV-1 negative and
positive pregnant women in Yaounde ´.
HIV Negative HIV positive p*
Peripheral Blood parasitemia n=14 n=14
1 0.08
#1/1000 13 8
2/1000–5/1000 1 3
$6/1000 0 3
Placental Parasitemia 8 9 0.04
#1/1000 8 4
2/1000–5/1000 0 1
$6/1000 0 4
p*: Chi Square Test.
1Peripheral blood parasitemia was not determined in 1 HIV-1 positive woman
with peripheral blood P-falciparum infection.
doi:10.1371/journal.pone.0008114.t002
Figure 1. Levels of cytokine mRNA expressed in the placenta of HIV-1 negative (left panel) and positive (right panel) women.
Cytokine mRNA were extracted from Cryo-preserved placenta fragments of HIV-1 negative and positive women. Reverse transcribed cytokine mRNA
were quantified by Real Time PCR. Results were normalized to references values of a HIV-1 negative placenta (Ref). Each dot represents one individual
placenta and the horizontal bar the median value. A total number of 50 placentas for HIV-1 negative and 80 for HIV-1 positive women were tested for
each cytokine. Comparison between the 2 groups was performed through Mann-Whitney test.
doi:10.1371/journal.pone.0008114.g001
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and protein) between the 7 transmitting and the 57 non-
transmitting HIV-1 positive mothers (data not presented) were
not significantly different.
The pro-inflammatory cytokine TNF-a is strongly
associated with clinical parameters known to be related
to MTCT of HIV-1
When analysing the association between placental cytokine
levels and the 9 clinical parameters investigated (the 6 parameters
described in table 1, plus for HIV-1 positive women, viral load,
CD4 T-cell number and delay between nevirapine uptake and
delivery), the pro-inflammatory cytokine TNF-a plays a particular
role with an association in 6 out of the 9 parameters, whereas one
or no association was observed for the other cytokines (Table 3).
Moreover, this association was observed with all the 4 clinical
parameters known to be related to MTCT of HIV-1. The
proportion of placenta with undetectable TNF-a protein level was
significantly associated with plasma viral load over 4.5 in log10/ml
(73% of values lower that the detection level (10pg/ml) versus
40%, p=0.008), with high delay between nevirapine uptake and
delivery (71% of values lower than the detection limit, versus 33%,
p=0.007), with CD4 T-cell number over 250/mm
3 (median level
lower than the detection limit versus 49 pg/ml, p=0.04). In
addition, high TNF-a expression level was significantly associated
with CD4 T-cell number over 250/mm
3 (median level of
4.86reference versus 2.8, p=0.02). These associations between
TNF-a protein secretion or expression levels and CD4 T-cell
numbers were confirmed through significant Spearman correla-
tion coefficient (20.29, p=0.01 and +0.27, p=0.02, respectively).
When analysing the association between placental cytokine levels
and the 6 parameters investigated in HIV-1 negative women, one
or no association was observed for all cytokines.
Placental cytokine profiles differ significantly between
HIV-1 positive and negative women, when taking into
account Plasmodium falciparum infection
The placental cytokine profiles were next analysed taking into
consideration the P. falciparum infection status of the women both
in the placenta and in the peripheral blood.
Messenger RNA or protein cytokine levels were compared
between HIV-1 positive and negative women in the presence or
absence of infection by P. falciparum in the peripheral blood
(Tables 4 and 5) or in the placenta (Tables 6 and 7). When
peripheral blood P. falciparum was negative, numerous significant
differences and trends were observed in placental cytokine levels
between HIV-1 negative and positive women (RNA- TNF-a, IL-
10 and TNF-a/IL-10, table 4; Proteins- IL-16, IL-7, undetect-
able IL-7, TNF-a, undetectable TNF-a, LIF, undetectable LIF,
and RANTES, table 5). Hence, there were significant lower levels
of TNF-a mRNA and TNF-a/IL-10 mRNA ratio in peripheral
blood P. falciparum negative women HIV-1 uninfected compared to
peripheral blood P. falciparum negative women HIV-1 infected
(Table 4). On the other hand in peripheral blood P. falciparum
positive women, fewer significant differences were observed in
placental cytokine levels between HIV-1 positive and negative
women (RNA- IL-8, table 4a; Proteins- IL-7, undetectable IL-7,
table 5).
Figure 2. Cytokine protein secretion in the culture supernatant after a 24 hour explant culture of placenta of HIV-1 negative (left
panel) and positive (right panel) women. Placental fragments were cultured for 24 hours after which culture supernatants were harvested.
Cytokines were quantified in the supernatants using commercially available ELISA kits. Each dot represents one individual placenta and the horizontal
bar, the median value. A total number of 50 placentas for HIV-1 negative and 80 for HIV-1 positive women were tested for each cytokine. For IL7, TNF-
a, IL-8 and LIF, the lowest values correspond to the assay detection limit. Comparisons between the 2 groups were performed through Mann-
Whitney test.
doi:10.1371/journal.pone.0008114.g002
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negative (Tables 6 and 7), several significant differences and trends
were observed in placental cytokine levels between HIV-1 positive
and negative women (RNA- IL-7, TNF-a, IL-10 and TNF-a/IL-
10, table 6; Proteins- IL-7, undetectable IL-7, undetectable
TNF-a, RANTES table 7). When placentas were P. falciparum
positive, fewer placental cytokine levels were significantly different
between HIV-1 positive and negative pregnant women (RNA- IL-
7, table 6; Proteins- IL-16, IL-7, undetectable IL-7, table 7).
There were significantly lower levels of TNF-a mRNA and
TNF-a/IL-10 mRNA ratio in placenta P.falciparum negative
women HIV-1 uninfected compared to placenta P.falciparum
negative women HIV-1 infected (Table 6).
It should be noted the lost of significant difference in the TNF-
a/IL-10 mRNA ratio between HIV-1 negative and positive
women in the presence of P. falciparum infection in both peripheral
blood and placenta (Tables 4 and 6).
Thus, placental cytokine profiles are profoundly modified by P.
falciparum infection, regardless of whether it is placental or systemic
malaria.
Discussion
The aim of this study was to assess the human placental cytokine
profiles attributable to HIV-1 infection in an African setting where
malaria and HIV infections are both endemic. Our analysis of raw
data revealed significant correlations between cytokines and HIV
associated clinical parameters with significant decrease of IL-7,
TNF-a, LIF, IL-16 and RANTES proteins median levels in HIV
positive women. These changes were however only meaningful if
malaria infection was considered as differences between the two
groups were dependant on the proportion of malaria positive
samples in each group. After stratification for the presence of
malaria in peripheral blood or within the placenta, highly
significant differences between the two groups were observed for
both expressed and secreted cytokines.
In this study we observed a similar distribution of clinical
parameters (age, duration of pregnancy, parity, body weight of
babies at delivery and the prevalence of other infections such as P.
falciparum, HBV, HCV and T. pallidum) in HIV-1 negative and
positive women. This finding is justified by the fact that HIV-1
positive and negative women were drawn from the same
environment and that HIV positive women included in this study
were not severely immuno-depressed as exemplified by an average
CD4 T-cell count of about 364 cells/mm
3. The significantly lower
levels of haemoglobin observed among HIV-1 positive women
(supplementary figure S1) is in agreement with earlier studies
[35,36], as well as the lower neutrophil counts which have been
proposed by some authors as due to a direct infection of a
neutrophil sub population expressing CD4 and CXCR4 surface
markers [37]. Another reason could be the fact that neutrophils in
HIV positive women are depleted by Fas (CD95) mediated
apoptosis [38]
Several studies reported significant differences in placental
cytokine levels between HIV-1 negative and positive women
[12,39,40]. In the present work, of the studied cytokines, TNF-a
only was significantly increased in HIV positive women at RNA
level. All the remaining cytokines were of comparable levels
between the two groups, contrasting with these earlier findings. At
the protein level, however, significant differences were observed
between HIV negative and HIV positive placenta cytokines, with a
systematic decrease in the group of HIV positive women. We
hypothesised that P. falciparum could masks some differences in
placental cytokine levels between HIV-1 negative and positive
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especially of pregnant women and is endemic to the study site. In
this study, we observed similar P. falciparum infection rates in both
groups. Conversely, there was a significantly higher parasite
density (parasitemia) among the HIV-1 positive women both in the
placenta as well as in the peripheral blood circulation. This result
indicates that both groups are equally exposed to P. falciparum
infection, but that HIV-1 positive women less efficiently limit P.
falciparum propagation. P. falciparum is known to sequestrate in the
placenta leading to the accumulation of parasitized erythrocytes in
the intervillous space, infiltration of inflammatory cells and release
of some placental cytokines [25,41]. The release of these cytokines
as a result of P. falciparum sequestration in the placenta significantly
modifies the placental cytokine environment [31,32,42]. Analysis
of our data, considering the P. falciparum status, showed that there
were significant differences in the placental cytokine levels of HIV-
1 negative and positive women (Table 6 and 7). In the absence of
P. falciparum infection, significant differences in the levels of several
placental cytokines were observed between HIV-1 negative and
positive women. However in women who were P. falciparum
positive, fewer cytokines were significantly different between HIV-
1 negative and positive women. Hence, the differences observed
without stratification with malaria between HIV-1 positive and
negative groups was dependant on the proportion of malaria
positive samples in each of the two groups. Indeed, since
differences in cytokine mRNA expression or secretion levels
between HIV positive and HIV negative women are different in
malaria infected and malaria non-infected women, as we clearly
observed. Thus, by altering the normal placental cytokine
environment, P. falciparum infection modifies or hides the impact
of HIV-1 on the very same environment.
In this study, P. falciparum is playing a confounding role in
placental cytokine analyses between HIV-1 negative and positive
women and should be taken into consideration when comparing
Table 5. Difference in placental cytokine secretion levels (Proteins) between HIV-1 negative and positive women in relation to
peripheral blood Plasmodium falciparum status.
Pb P.falciparum negative Pb P.falciparum positive
HIV-1 Negative (n=36) HIV-1 Positive (n=62) p* HIV-1 Negative (n=14) HIV-1 Positive (n=15) p*
Protein (pg/ml)
IL-16 569 (480–674) 417 (227–672) 0.007
1 685 (449–991) 596 (441–764)
** 0.41
IL-7 21 (16–26) ,9( ,9–24) ,0.001
1 25 (19–34) ,9( ,9–14) ,0.001
1
IL-7 Undetectable 0% 53% ,0.001
1 0% 67% ,0.001
1
TNF-a 18 (,10–54) ,10 (,10–45) 0.05
1 25 (,10–62) 20 (,10–48) 0.72
TNF-a Undetectable 19% 53% 0.001
1 29% 33% 0.78
LIF 81 (42–104) 42 (,19–96) 0.01
1 68 (35–97) 83 (,19–112) 0.83
LIF Undetectable 22% 45% 0.02
1 21% 33% 0.47
IL-8 3355 (1841–5245) 3460 (2288–6760) 0.63 3121 (1349–5335) 2935 (2114–5368) 0.66
IL-8 Undetectable 0% 2% 0.44 14% 0% 0.22
IL-15 34 (25–44) 31 (23–46) 0.46 34 (32–39) 32 (21–38) 0.28
RANTES 981 (747–1541) 795 (529–1251) 0.03
1 770 (657–1201) 713 (630–1057) 0.86
The values are indicated as median and inter-quartile range. p*: Mann-Whitney Test; Pb=peripheral blood;
1=significant difference (P,0.05);
2=trend (0.05,p,0.15);
**n=14.
doi:10.1371/journal.pone.0008114.t005
Table 4. Difference in placental cytokine expression levels (RNA) between HIV-1 negative and positive women in relation to
peripheral blood Plasmodium falciparum status.
Cytokines Pb P.falciparum negative Pb P.falciparum positive
HIV-1 Negative (n=36) HIV-1 Positive (n=62) p HIV-1 Negative (n=14) HIV-1 Positive (n=15) p*
RNA (x ref)
SDF-1 1.5 (1.2–3.3) 2.0 (1.0–3.0)
* 0.97 1.8 (0.8–3.5) 1.7 (1.0–3.5) 0.54
IL-7 0.7 (0.0–2.1) 0.7 (0.3–1.7) 0.88 1.4 (0.1–2.5) 0.7 (0.5–1.5) 0.74
TNF-a 1.8 (0.9–6.5) 4.2 (2.3–12.5) 0.009 3.2 (2.0–5.8) 3.2 (1.1–5.7) 0.79
IL-10 3.1 (1.8–7.3) 2.1 (1.1–5.0) 0.07
2 4.8 (1.3–7.4) 3.6 (1.2–5.1) 0.28
IL-8 16.4 (2.7–40.1) 11.4 (5.3–31.0) 0.84 8.0 (3.3–17.0) 12.6 (6.7–32.2) 0.12
2
TNF-a/IL-10 0.8 (0.3–1.9) 2.0 (0.7–5.1) 0.001
1 0.9 (0.4–2.0) 1.0 (0.4–1.6) 0.73
The mRNA expression levels are referenced to a term placental tissue (reference calibrator: cal). The amount of target gene in the sample and in the calibrator was
normalised to the endogenous reference (18S RNA). The values are indicated as median and inter-quartile range. p*: Mann-Whitney Test; Pb=peripheral blood;
1=significant difference (P,0.05);
2=trend (0.05,p,0.15).
doi:10.1371/journal.pone.0008114.t004
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Modification of the placental cytokine environment could have
varying consequences in MTCT of HIV-1. The precise mecha-
nism by which malaria and HIV infections interact to influence
MTCT of the virus still remains to be uncovered. However,
several studies have pointed out the predominant role of pro-
inflammatory cytokines, especially TNF-a, on this interference.
Several groups in Cameroon have shown that TNF-a is secreted in
the placenta infected by P. falciparum [31,32].
In our study, no difference in placental cytokine profiles could
be evidenced between transmitting and not transmitting mothers,
but this is likely to be due to the few number of HIV-1 infected
children. When looking for associations between placental
cytokine levels and clinical parameters, the observation of the
association between a cytokine level and only one clinical
parameter was considered as chance related due to the numerous
tests of association performed. Not surprisingly, the only placental
cytokine that was associated to several clinical parameters was
TNF-a. Especially, TNF-a level was associated with all the four
clinical parameters studied here known to be related to MTCT of
HIV-1. However, the negative sign of association between TNF-a
(protein) with CD4, plasma viral load and rupture of membrane
more than 4 hours is surprising. A plausible explanation could be
again the confounding effect of P. falciparum. Other groups have
shown this cytokine in the placenta to be associated with low birth
weight [30,33] another risk factor for MTCT of HIV-1. Several
authors have reported that TNF-a stimulates HIV-1 replication in
infected cell lines by an LTR-driven manner [13,43]. In particular
our group showed that TNF-a stimulates HIV-1 replication in
human term placentas obtained after elective caesarean section
[21]. Our data on the associations of these clinical parameters with
TNF-a essentially due to pregnancy associated malaria are thus in
line with these previous observations. It is noteworthy that, at the
mRNA level, the unique statistically significant difference in
Table 7. Difference in Placental cytokine secretions levels (Protein) between HIV-1 negative and positive women in relation to
Placental Plasmodium falciparum status.
Cytokines Pl P.falciparum Negative Pl P.falciparum Positive
HIV-1 Negative (n=37) HIV-1 Positive (n=29) p* HIV-1 Negative (n=8) HIV-1 Positive (n=9) p*
Protein (pg/ml)
IL-16 557 (473–695) 559 (283–819)
** 0.79 926 (632–1087) 666 (532–706) 0.08
2
IL-7 21.0 (16.5–26.3) ,9( ,9–22.2) 0.001
1 29.2 (25.3–51.0) ,9( ,9–23.8) 0.02
1
IL-7 undetectable 0% 55% ,0.001
1 0% 56% 0.01
1
TNF-a 25.3 (13.6–58.7) 29.0 (,10–52.0) 0.68 16.1 (6.1–125.7) 24.9 (,10–49.6) 0.77
TNF-a undetectable 14% 37% 0.04
1 25% 33% 0.71
LIF 81 (47–112) 76 (,19–107) 0.61 70 (45–87) 94 (44–115) 0.16
LIF undetectable 22% 30% 0.39 13% 22% 0.60
IL-8 3523 (1620–5273) 2935 (1653–4784) 0.41 2835 (1368–3370) 3916 (2686–6836) 0.15
IL-8 Undetectable 12% 0% 0.27
IL-15 34 (28–42) 33 (26–53) 0.86 33 (23–42) 36 (26–47) 0.29
RANTES 953 (737–1321) 790 (511–1252) 0.09
2 758 (570–1126) 703 (620–1031) 0.77
The mRNA expression levels are referenced to a term placental tissue (reference calibrator: cal). The amount of target gene in the sample and in the calibrator was
normalised to the endogenous reference (18S RNA). The values are indicated as median and inter-quartile range. p*: Mann-Whitney Test; Pl=placental; 1=significant
difference (P,0.05); 2=trend (0.05,p,0.15); **n=27.
doi:10.1371/journal.pone.0008114.t007
Table 6. Difference in Placental cytokine expression levels (RNA) between HIV-1 negative and positive women in relation to
Placental Plasmodium falciparum status.
Cytokines Pl P.falciparum Negative Pl P.falciparum Positive
HIV-1 Negative (n=37) HIV-1 Positive (n=29) p* HIV-1 Negative (n=8) HIV-1 Positive (n=9) p*
RNA (x ref)
SDF-1 1.5 (1.0–3.6) 2.1 (0.8–3.0)
* 0.87 1.6 (1.2–2.3) 1.3 (1.0–2.0) 0.70
IL-7 0.8 (0.0–2.4) 0.4 (0.1–0.8) 0.10
2 0.8 (0.0–2.1) 1.3 (0.7–1.7) 0.70
TNF-a 2.2 (0.9–5.0) 4.5 (1.2–10.8) 0.12
2 3.9 (1.1–9.4) 3.9 (2.7–16.6) 0.92
IL-10 3.3 (1.5–7.6) 1.9 (1.1–5.4) 0.08
2 5.0 (3.4–7.0) 3.6 (1.4–5.6) 0.34
IL-8 15.8 (1.5–37.8) 10.1 (4.5–35.2) 0.87 8.0 (5.8–12.7) 12.6 (6.6–25.6) 0.34
TNF-a/IL-10 0.8 (0.3–1.8) 1.6 (0.5–4.8) 0.03
1 0.8 (0.3–1.2) 1.1 (0.5–5.7) 0.44
The mRNA expression levels are referenced to a term placental tissue (reference calibrator: cal). The amount of target gene in the sample and in the calibrator was
normalised to the endogenous reference (18S RNA). The values are indicated as median and inter-quartile range. p*: Mann-Whitney Test; Pl=placental; 1=significant
difference (P,0.05); 2=trend (0.05,p,0.15); * n=28.
doi:10.1371/journal.pone.0008114.t006
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controls observed in the present study was on the ratio TNF-a to
IL-10 levels. Indeed, TNFa and IL-10 are two prototypic pro-and
anti-inflammatory cytokines, respectively, whose roles in HIV-1
replication and during malaria infection are well described
[13,14,32,41,44,45], This difference is not significant anymore in
the presence of P. falciparum infection. This observation underlines
the importance of the notion of the pro- and anti- inflammatory
balance, especially for these two major cytokines, in the context of
pregnancy and infection with pathogens [13,46,47].
Considering the high prevalence of P. falciparum among
pregnant women observed in this study and others [48], we could
therefore expect an HIV-1/P.falciparum interaction at the level of
the placenta and this could probably explain the high levels of in
utero MTCT of HIV-1 observed during malaria peak periods in the
rainy season [49]. The P. falciparum/HIV-1 interactions in the
placenta are also an important morbidity factor [50].
This study was part of a multicentric study comprising two other
sites, France where combined therapies were administered to
pregnant women for PMTC of HIV-1 and Thailand where bi-
therapy was administered. Both sites had very little or insignificant
infections by P.falciparum. Considering that only a single dose of
NVP was administered to the women in Cameroon just before
delivery, it could be suggested, on the basis of the short exposure
time to this single dose monotherapy, that there was little or no
effect on the placental cytokine environment due the drug. On the
other hand, our collaborators from the French and Thai sites
showed evidence of impact of ARV on placental cytokines [40,51].
The take home message of our results here is that P. falciparum
infection plays a significant role in altering the placental subtle
equilibrium of cytokine profiles and is a confounding factor for the
comparison between HIV negative and positive women. This
underlines the complex impact and interaction of both pathogens
at the level of the placenta. This should be taken into consideration
in further studies aiming to evaluate the impact of P.falciparum on
HIV-1 MTCT.
Materials and Methods
Ethical consideration
The study was reviewed and approved by the Cameroon
national ethical committee and by the Cameroon Health
authorities. All women included in the study gave their written
informed consent.
Study site
The present study was carried out in the framework of a public
health program for the prevention of HIV-1 mother-to-child
transmission, in Yaounde ´, Cameroon [52]. The study sites
included the maternity of the Central Hospital, the Chantal Biya
Mother and Child Healthcare centre (FCB) and the CASS of
Nkolndongo in Yaounde ´. All the biological analyses were carried
out in the Centre Pasteur du Cameroun (CPC).
Subjects
Pregnant women were recruited within these sites between June
2001 and October 2004. The HIV sero-status of the women was
determined by applying the national diagnostic algorithm of two
rapid tests. Indeterminate cases were confirmed in the CPC using a
previously described algorithm [52]. During that period, 80 HIV-1
positive women were included between the beginning of their
second trimester of gestation and delivery. Only women infected by
HIV-1belongingtotheMajorgroup(groupM)andnotunderARV
therapy for their disease were included. In addition, they should
have agreed to take a tablet of nevirapine at the beginning of labour
and also a single dose was given to the baby within the first 72 hours
oflife aspracticedinCameroon at the timeofthestudy.Inclusionof
HIV-1 negative women was initiated in September 2002 and 50 of
them were included, mostly at delivery. Whatever HIV-1 status,
women recruited before delivery were regularly followed-up until
they delivered. Women were excluded from the study if they were
not resident in Yaounde ´ or if they did not give a written informed
consent. Women with multiple pregnancies or those who delivered
through caesarean sections were also excluded.
Biological samples
At inclusion, 265ml of maternal venous blood was collected in
EDTA-treated tubes for whole blood count, malaria parasite,
Hepatitis B- and C-viruses, and Syphilis diagnoses. In addition,
CD4 counts and viral load quantification were performed for
HIV-1 positive pregnant women on the same samples. Placentas
were collected and processed within 3 hours following delivery.
From the placentas, different types of samples were prepared.
Firstly, thick and thin blood films from the maternal side of the
placentas were prepared to look for malaria parasites. Secondly,
after extensive washings with phosphate buffered saline (PBS),
chorionic villi explants (3g/20 ml of culture medium) were cultured
for 24 hours at 37uC in humidified atmosphere containing 5%
CO2. Thirdly, after extensive washings, chorionic villi fragments
were stored in RNAlater (Qiagen) for subsequent RNA extraction
and cytokine RNA quantification by real time PCR (ABIPrism
7000). Placenta preparation for malaria as described above could
only start in October 2002 and was thus performed on placenta
from 45 HIV-1 negative women and 38 HIV-1 positive women.
Complete blood count
An automated counter (ABX Pentra 120) was used to measure
complete blood cell count, the quantity and percentages of each
type of blood cells was tallied, including neutrophils. Haemoglobin
was also quantified.
Malaria parasite screening
Thin and thick blood and placenta smears were prepared,
stained with Giemsa and examined microscopically for malaria
parasites. Parasite load was expressed as the number of asexual
forms of P. falciparum per 1000 red blood cells.
Serologies (HIV, HBV, HCV and Syphilis)
Commercial Enzyme Immuno Assay (EIA) kits were used for
plasma analysis. HIV screening was performed using an algorithm
of rapid tests as approved by the National Committee for the Fight
against HIV in Cameroon. Positive cases were confirmed in the
laboratory of virology of the Centre Pasteur du Cameroun as
previously reported [52]. HBV (MONOLISA Ag HBs PLUS
BIO-RAD, France) and HCV (MONOLISA HCV PLUS version
2, BIO-RAD, France) were tested following manufacturer’s
instructions. A combination of two tests was used for syphilis
diagnosis, namely VDRL (BioMe ´rieux) followed by TPHA
(BioRad). CD4 cell counts were performed using the flow
cytometry technique (Becton Dickinson FACSCount
TM System).
Direct quantification of viral particles was done using the
branched-DNA technique (QuantiplexH HIV-RNA).
Secreted cytokine quantification by ELISA
After extensive washing to remove residual maternal blood,
three grams of placental fragments were cultured in 20ml of
culture medium made up of RPMI 1640 (Gibco BRL life
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glutamine (Gibco BRL life technologies), and 1% penicillin/
streptomycin (Gibco BRL life technologies). After 24 hours of
culture at 37uC and 5% CO2, culture supernatants were
harvested, centrifuged at 3 000 rpm for 30 minutes and several
aliquots were stored at 280uC for cytokine quantification by
ELISA. Several cytokines including pro-inflammatory, Th1/Th2
type cytokines, and chemokines, were assayed using quantitative
commercial sandwich enzyme immunoassay kits. The following
cytokines were analyzed: TNF-a (Cell Com, Beckman Coulter
Company; sensitivity 10pg/ml), IL-8 (Quantikine, R&D systems;
sensitivity 10pg/ml), RANTES (Quantikine, R&D systems;
sensitivity 8pg/ml), IL-15 (Quantikine, R&D systems; sensitivity
2pg/ml), LIF (Screening done by an ÆÆin houseææ test of the
laboratory of Immunology, University of Bordeaux 2; sensitivity
19 pg/ml) [53], IL-7 (BioSource International; sensitivity 9pg/ml),
IL-16 (BioSource International; sensitivity 5pg/ml) and IL-10 (Cell
Com, Beckman Coulter Company; sensitivity 5 pg/ml).
Cytokine RNA quantification by real time PCR
RNA later cryo-conserved and washed placental fragments were
brought to room temperature, RNAs extracted using the RNeasy
Mini kit (Qiagen) and stored in RNA guard (Amersham Pharmacia
Biotech Inc). Reverse transcriptase PCR was performed using the
RT reaction kit (Applied Biosystems, Roche) consisting of the
following:106RTBuffer, 5.5 mMMgCl2,5 0 0mM/dNTP, 2.5mM
Random Hexamer, 0.4 unit/ml RNase inhibitor, 1.25unit/ml
Multiscribe RT, RNA sample (10pg–2mg) and the thermal cycler
was programmed with an incubation period of 10 minutes at 25uC,
reverse transcription at 48uC for 30 minutes and reverse transcrip-
tase inactivation at 95uC for 5 minutes. The ensuing cDNAs were
quantified using ABIPrism 7000 (Applied Biosystems).
For mRNA quantification, pre-developed reagents from
Applied Biosystems were used for IL-7, IL-8 and TNF-a while
‘‘in house’’ developed primers and probes were used for SDF-1
and IL-10; 206 PreDev Target Mixed Reagents (PE Applied
Biosystems) were used together with 206human 18S rRNA Pre-
developed Taqman assay (internal controls), 5ml of cDNA and the
total volume adjusted to 25ml using RNase/DNase-free Water (Bio
101 Systems). The specific oligonucleotide primer sets and
TaqmanH probes used to amplify SDF-1 and IL-10 have been
described previously [54]. SDF-1 and IL-10 primers and probes
were used together with 206 human 18S rRNA Pre-developed
Taqman assay, 5ml of cDNA and volume adjusted to 25ml using
RNase/DNase-free Water (Bio 101 systems). The thermal cycler
was programmed with the following conditions: 50uC for
2 minutes, 95uC for 10 minutes and then the amplifications with
an initial denaturation step at 95uC for 15 seconds followed by
annealing/extension at 60uC for 1 min for a total of 40 cycles. All
samples were treated in triplicates. Results are presented in
comparison to a reference HIV-1 negative placenta.
Statistical analysis
The profiles of secreted cytokines (ELISA) among HIV-1
positive and negative women who were P. falciparum positive or
negative in the peripheral blood circulation or in the placenta is
described through median and inter-quartile range (25
th and 75
th
percentiles) and/or by the proportion of samples with undetectable
level in each group. The placental cytokine (RNA) profiles are
described in the same way within each group through median and
inter-quartile range. The comparison of these distributions
between the groups was performed through non-parametric tests,
Kruskal-Wallis test in case the number of groups compared is
more than two or the Mann-Whitney test in case two groups are
compared. As regards proportion of undetectable values, compar-
isons were realised with the chi square test or the Fisher’s exact test
when necessary. Association in HIV-1 positive women between
the different cytokine protein secretions or mRNA expressions and
clinical parameters known to be related with MTCT of HIV-1 was
tested through Spearman correlation test for quantitative clinical
parameters and Mann-Whitney or Kruskal-Wallis test for
qualitative ones. Significant differences or associations were
defined by a p,0.05 whereas trends were observed for p values
between 0.05 and 0.15.
Supporting Information
Figure S1 Box-plot of hemoglobin (bottom panel) and neutro-
phil (upper panel) distributions in the blood of HIV-1 negative and
positive pregnant women. Hemoglobin and neutrophil levels were
quantified in blood samples of pregnant women by an automated
counter. Distributions are represented per group as median, inter-
quartile range, 95% confidence interval and values outside this
interval. Comparisons between the 2 HIV-1 groups were
performed through Mann Whitney test.
Found at: doi:10.1371/journal.pone.0008114.s001 (1.16 MB TIF)
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